This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Hemorrhagic transformation (HT) is a major complication in ischemic stroke, associated with increased morbidity and mortality. Identifying ischemic stroke patients at risk of HT could have substantial clinical implications, especially in the setting of thrombolytic therapy. Acute stroke patients at very high risk for HT could foreseeably have alternative treatment, such as a modified dose of thrombolytic agent or coadministration of a second agent able to reduce HT risk.
In this issue of Neurology®, Kazmierski et al.1 sought to predict clinical deterioration due to HT in ischemic stroke by measurements of proteins in blood. A total of 458 stroke patients were enrolled in their study, 85 of whom experienced clinical deterioration, and 33 of whom had HT. Stroke patients who developed HT had increased fasting glucose and decreased platelet count compared to those …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients
Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome
Safety and efficacy of remote ischemic postconditioning after thrombolysis in patients with stroke
Extracellular matrix in the CNS